no scripts enabled
Medikabazaar
Cart
Ryzodeg Penfill 100Iu 3ml Injection

Your Advantages

Brand novo-nordisk

Ryzodeg Penfill 100IU 3ml Injection contains Insulin Degludec and Insulin Aspart, a combination of long-acting and rapid-acting insulins, used to manage type 1 and type 2 diabetes mellitus in adults and children.

 

Benefits

This medicine provides flexible and convenient blood sugar control. The long-acting insulin component helps maintain steady insulin levels throughout the day and night, while the rapid-acting insulin manages blood sugar spikes after meals. This dual action helps reduce the number of injections needed, improves glycemic control, and lowers the risk of hypoglycemia, especially at night.

 

Uses and Indications

  • Treatment of Type 1 diabetes mellitus in adults, adolescents, and children from 2 years of age.
  • Treatment of Type 2 diabetes mellitus in adults, adolescents, and children from 2 years of age.

The Ryzodeg Penfill 100IU 3ml Injection contains:

  • Insulin Degludec (2.56mg/1ml) and Insulin Aspart (1.05mg/1ml).
  • Each mL of solution contains 100 units of insulin degludec/insulin aspart in a 70/30 ratio.
  • One 3ml cartridge contains 300 units of insulin degludec/insulin aspart.
Active Ingredient(s)Insulin Degludec (2.56mg/1ml) + Insulin Aspart (1.05mg/1ml); 100 units/ml (70% Degludec, 30% Aspart)
Therapeutic ClassAnti Diabetic
Route of AdministrationSubcutaneous Injection
Storage ConditionsStore in a refrigerator (2°C – 8°C) before first use. After opening, store at room temperature (below 30°C) or in a refrigerator (2°C – 8°C) for up to 28 days. Do not freeze. Protect from light.
Regulatory ApprovalPrescription Required (Schedule H Drug)
Licensed IndicationsTreatment of Type 1 and Type 2 Diabetes Mellitus in adults, adolescents, and children from 2 years of age

Dosage and Administration

  1. Use Ryzodeg Penfill 100IU 3ml Injection strictly as directed by your doctor or nurse.
  2. It is usually taken once daily with a main meal, preferably at the same time each day.
  3. If administration at the same time is not possible, it may be taken at a different time, ensuring a minimum gap of 8 hours between doses.
  4. Administer the injection subcutaneously (under the skin) into the thigh, upper arm, or abdomen.
  5. Rotate the injection site within the same region to reduce the risk of lipodystrophy.
  6. Do not inject into a vein or muscle.

 

Storage and Disposal

  • Before first use, store Ryzodeg Penfill in a refrigerator between 2°C and 8°C.
  • Do not freeze the medicine.
  • After first opening, the pen can be stored at room temperature (below 30°C) or in a refrigerator (2°C – 8°C) for up to 4 weeks (28 days).
  • Keep the cap on the pen to protect it from light.
  • Keep out of reach of children.

Precautions and Safety

  • Do not use Ryzodeg if you are allergic to insulin degludec, insulin aspart, or any other ingredients.
  • Consult your doctor if you have a history of kidney, liver, or heart problems.
  • Pregnant or breastfeeding women should consult their doctor before using this medicine.
  • Monitor your blood sugar levels regularly as advised by your doctor.
  • Avoid excessive alcohol consumption, as it can lead to low blood sugar levels (hypoglycemia).
  • Do not stop taking this medicine without consulting your doctor, as it may lead to very high blood sugar levels.

 

Side Effects and Risks

  • The most common side effect is low blood sugar levels (hypoglycemia), which can be serious.
  • Other common side effects include allergic reactions, injection site reactions (pain, redness, swelling, itching), lipodystrophy (skin changes at the injection site), itching, rash, edema, and weight gain.
  • Seek immediate medical attention if you experience severe allergic reactions such as rash, hives, wheezing, trouble breathing, or swelling of the face, lips, tongue, or throat.

 

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.

twitterlinkedinfacebookinstagramyoutube
@Copyright Boston Ivy Healthcare Solutions Private Limited